Promoting Cholesterol Screening

Sponsor
Northwestern University (Other)
Overall Status
Completed
CT.gov ID
NCT01930149
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
480
3
2
6
160
26.8

Study Details

Study Description

Brief Summary

Cholesterol screening is an important prerequisite for cardiovascular disease (CVD) risk assessment. Cholesterol screening is recommended by the United States Preventive Services Task Force (USPSTF). Since reminder systems have been shown to modestly improve the rates of preventive services, including in safety net settings, we will implement patient-directed reminders to health center patients who meet our eligibility criteria.

The aim of this study is to determine if a mailed outreach message and facilitated ordering of screening lipid tests increases cholesterol screening test completion within 3 months among federally qualified community health center patients who are eligible for screening compared to usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mailed patient outreach intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
480 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Study Start Date :
Dec 1, 2013
Actual Primary Completion Date :
Mar 1, 2014
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mailed patient outreach intervention

Participants randomized to this arm will receive mailed letter from health center that encourages cholesterol testing and describes the steps necessary to obtain the test at the patient's care site. Clinic staff will facilitate the ordering of tests for patients who may not have an office visit.

Behavioral: Mailed patient outreach intervention
This study's intervention is a mailed outreach letter from the health center that encourages cholesterol testing and describes the steps necessary to obtain the test at the patient's care site. Clinic staff will facilitate the ordering of tests for patients who may not have an office visit.

No Intervention: Usual Care Control Group

Participants randomized to this arm will receive usual care.

Outcome Measures

Primary Outcome Measures

  1. Completion of total cholesterol and HDL cholesterol test or full lipid panel [within 3 months of outreach]

    Primary outcome will be completion of total cholesterol and HDL cholesterol test or a full lipid panel recorded within GE Centricity electronic health record at the patient's clinical site.

Secondary Outcome Measures

  1. Statin prescription [within 3 months of outreach]

    Secondary outcome is prescription of a statin as assessed by automated electronic queries of electronic health record.

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient at participating health center

  • At least 1 visit to clinic in the prior 12 months

  • No total cholesterol and high-density lipoprotein cholesterol result recorded in the electronic health record in the past 5 years

  • No cholesterol screening order placed within the previous 3 months

  • Men 35-75 years old, or women 45-75 years old who also have one of the following: hypertension, obesity, or current smoking

Exclusion Criteria:
  • Previously diagnosed cardiovascular disease, peripheral arterial disease or diabetes mellitus

  • Statin on active medication list

  • Preferred language other than English or Spanish

Contacts and Locations

Locations

Site City State Country Postal Code
1 North Country Health Care Flagstaff Arizona United States 86004
2 Near North Health Service Corporation Chicago Illinois United States 60610
3 Heartland Health Outreach Chicago Illinois United States 60645

Sponsors and Collaborators

  • Northwestern University
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Stephen D Persell, MD, MPH, Northwestern University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stephen Persell, Assistant Professor, Northwestern University
ClinicalTrials.gov Identifier:
NCT01930149
Other Study ID Numbers:
  • 1PO1HS021141-01-Project 2B
First Posted:
Aug 28, 2013
Last Update Posted:
Sep 29, 2014
Last Verified:
Sep 1, 2014
Keywords provided by Stephen Persell, Assistant Professor, Northwestern University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2014